David Misiaszek is a Gilman, Connecticut based nurse practitioner. Active license number of David Misiaszek is 11670 for Family in Connecticut. His current practice location is 480 Fitchville Rd, Gilman. Patients can reach him at 860-961-4923. David Misiaszek is NP and his NPI number (Unique professional ID assigned by NPPES) is 1336847003. David Misiaszek has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
David Misiaszek speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1336847003
NPI Enumeration Date:
21 Feb, 2023
NPI Last Update On:
10 May, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David Misiaszek are as mentioned below.
License Number
Specialization
State
Status
11670
Family
Connecticut
Primary
E55459
Nurse Practitioner
Connecticut
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
David Misiaszek 480 Fitchville Rd, Gilman, Connecticut
Zip:
06336-1000
Phone Number:
860-961-4923
Patients can reach David Misiaszek at 480 Fitchville Rd, Gilman, Connecticut or can call to book an appointment on 860-961-4923.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.